Paired multiplex reverse-transcriptase polymerase chain reaction (PMRT-PCR) analysis as a rapid and accurate diagnostic tool for the detection of MLL fusion genes in hematologic malignancies

Leukemia

Volumn 15, Issue 8, 2001, Pages 1293-1300

  Andersson, A ^a   Hoglund M ^a   Johansson, B ^a   Lassen, C ^a   Billstrom R ^a   Garwicz, S ^a   Nilsson, P G ^a   Mitelman, F ^a   Fioretos, T ^a  

^a LUND UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Acute lymphoblastic leukemia; Acute myeloid leukemia; MLL; Multiplex reverse transcriptase polymerase chain reaction

Indexed keywords

PRIMER DNA;

ACUTE GRANULOCYTIC LEUKEMIA; ACUTE LYMPHOBLASTIC LEUKEMIA; ADOLESCENT; ADULT; ARTICLE; CANCER SURVIVAL; CHILD; CHILDHOOD LEUKEMIA; CHIMERA; CHROMOSOME 10P; CHROMOSOME 10Q; CHROMOSOME 11P; CHROMOSOME 11Q; CHROMOSOME 13P; CHROMOSOME 13Q; CHROMOSOME 19P; CHROMOSOME 19Q; CHROMOSOME 4Q; CHROMOSOME 6Q; CHROMOSOME 9P; CHROMOSOME 9Q; CHROMOSOME ANALYSIS; CHROMOSOME BAND; CHROMOSOME TRANSLOCATION 10; CHROMOSOME TRANSLOCATION 11; CHROMOSOME TRANSLOCATION 13; CHROMOSOME TRANSLOCATION 19; CHROMOSOME TRANSLOCATION 4; CHROMOSOME TRANSLOCATION 6; CHROMOSOME TRANSLOCATION 9; CLINICAL ARTICLE; CLINICAL PROTOCOL; CONTROLLED STUDY; DATA ANALYSIS; DIAGNOSTIC ACCURACY; DIAGNOSTIC PROCEDURE; FEMALE; FUSION GENE; GENE AMPLIFICATION; GENE REARRANGEMENT; GENETIC ANALYSIS; HEMATOLOGIC DISEASE; HUMAN; HUMAN CELL; LEUKEMIA CELL LINE; MEDICAL DECISION MAKING; NUCLEOTIDE SEQUENCE; PATHOGENESIS; PRIORITY JOURNAL; PROGNOSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SENSITIVITY AND SPECIFICITY;

EID: 0034890351     PISSN: 08876924     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.leu.2402189     Document Type: Article

References (65)

1. Rearrangements of the MLL gene in therapy-related acute myeloid leukemia in patients previously treated with agents targeting DNA-topoisomerase II
2. The critical role of chromosome translocations in human leukemias
3. Genes altered by chromosomal translocations in leukemias and lymphomas
4. Mll rearrangements in haematological malignancies: Lessons from clinical and biological studies
5. Exon/intron structure of the human ALL-1 (MLL) gene involved in translocations to chromosomal region 11q23 and acute leukaemias
6. A trithorax-like gene is interrupted by chromosome 11q23 translocations in acute leukaemias
7. The t(4;11) chromosome translocation of human acute leukemias fuses the ALL-1 gene, related to Drosophila trithorax, to the AF-4 gene
8. Involvement of a homolog of Drosophila trithorax by 11q23 chromosomal translocations in acute leukemias
9. Rearrangement of the MLL gene in acute lymphoblastic and acute myeloid leukemias with 11q23 chromosomal translocations
10. Mitelman database of chromosome aberrations in cancer
11. Hematologic malignancies with t(4;11)(q21;q23) - A cytogenetic, morphologic, immunophenotypic and clinical study of 183 cases
12. The translocations, t(11;19)(q23;p13.1) and t(11;19)(q23;p13.3): A cytogenetic and clinical profile of 53 patients
13. Treatment outcome and prognostic factors for infants with acute lymphoblastic leukemia treated on two consecutive trials of the Children's Cancer Group
14. Childhood acute lymphoblastic leukemia with the MLL-ENL fusion and t(11;19)(q23;p13.3) translocation
15. The t(6;11)(q27;q23) translocation in acute leukemia: A laboratory and clinical study of 30 cases
16. The t(10;11)(p12;q23) translocation in acute leukaemia: A cytogenetic and clinical study of 20 patients
17. Hematological malignancies with t(9;11)(p21-22;q23) - A laboratory and clinical study of 125 cases
18. Adult patients with de novo acute myeloid leukemia and t(9;11)(p22;q23) have a superior outcome to patients with other translocations involving band 11q23: A cancer and leukemia group B study
19. Abnormalities of chromosome band 11q23 and the MLL gene in pediatric myelomonocytic and monoblastic leukemias. Identification of the t(9;11) as an indicator of long survival
20. Cytogenetic heterogeneity in t(11;19) acute leukemia: Clinical, hematological and cytogenetic analyses of 48 patients - Updated published cases and 16 new observations
21. MLL and CALM are fused to AF10 in morphologically distinct subsets of acute leukemia with translocation t(10;11): Both rearrangements are associated with a poor prognosis
22. Rapid and sensitive detection of all types of MLL gene translocations with a single FISH probe set
23. Comparison of cytogenetics, Southern blotting, and fluorescence in situ hybridization as methods for detecting MLL gene rearrangements in children with acute leukemia and with 11q23 abnormalities
24. ALL-1 gene at chromosome 11q23 is consistently altered in acute leukemia of early infancy
25. Detection of minimal residual disease in patients with AML1/ETO-associated acute myeloid leukemia using a novel quantitative reverse transcription polymerase chain reaction assay
26. Detection and quantification of residual disease in chronic myelogenous leukemia
27. Quantitation of minimal residual disease in acute promyelocytic leukemia patients with t(15;17) translocation using real-time RT-PCR
28. Detection of four different 11q23 chromosomal abnormalities by multiplex-PCR and fluorescence-based automatic DNA-fragment analysis
29. Multiplex reverse transcription-polymerase chain reaction for simultaneous screening of 29 translocations and chromosomal aberrations in acute leukemia
30. Multiplex PCR - A rapid screening method for detection of gene rearrangements in childhood acute lymphoblastic leukemia
31. Detection of prognostic significant translocations in childhood acute lymphoblastic leukaemia by one-step multiplex reverse transcription polymerase chain reaction
32. A serine/proline-rich protein is fused to HRX in t(4;11) acute leukemias
33. Analysis of the t(6;11)(q27;q23) in leukemia shows a consistent breakpoint in AF6 in three patients and in the ML-2 cell line
34. Molecular analysis of the MonoMac 6 cell line: Detection of an MLL-AF9 fusion transcript
35. Molecular cloning of 19p13 breakpoint region in infantile leukemia with t(11;19)(q23;p13) translocation
36. Two distinct portions of LTG19/ENL at 19p13 are involved in t(11;19) leukemia
37. A reverse transcriptase-polymerase chain reaction detects heterogeneous chimeric mRNAs in leukemias with 11q23 abnormalities
38. Human chronic myelogenous leukemia cell line with positive Philadelphia chromosome
39. NB4, a maturation inducible cell line with t(15;17) marker isolated from a human acute promyelocytic leukemia (M3)
40. Clinical impact of breakpoint position within M-bcr in chronic myeloid leukemia
41. Exon/intron structure of the human AF-4 gene, a member of the AF-4/LAF-4/FMR-2 gene family coding for a nuclear protein with structural alterations in acute leukaemia
42. What significance should we attribute to the detection of MLL fusion transcripts?
43. Alternative RNA splicing of the MLL gene in normal and malignant cells
44. Exon scrambling of MLL transcripts occur commonly and mimic partial genomic duplication of the gene
45. ALL1 gene alterations in acute leukemia: Biological and clinical aspects
46. Genes on chromosomes 4, 9, and 19 involved in 11q23 abnormalities in acute leukemia share sequence homology and/or common motifs
47. Heterogeneity in MLL/AF-4 fusion messenger RNA detected by the polymerase chain reaction in t(4;11) acute leukemia
48. Acute mixed-lineage leukemia t(4;11)(q21;q23) generates an MLL-AF4 fusion product
49. Clinical significance of MLL-AF4 fusion transcript expression in the absence of a cytogenetically detectable t(4;11)(q21;q23) chromosomal translocation
50. Detection of ALL-1/AF4 fusion transcript by reverse transcription-polymerase chain reaction for diagnosis and monitoring of acute leukemias with the t(4;11) translocation
51. Standardized RT-PCR analysis of fusion gene transcripts from chromosome aberrations in acute leukemia for detection of minimal residual disease. Report of the BIOMED-1 Concerted Action: Investigation of minimal disease in acute leukemia
52. Cloning of the ALL-1 fusion partner, the AF-6 gene, involved in acute myeloid leukemias with the t(6;11) chromosome translocation
53. Incidence and characterization of MLL gene (11q23) rearrangements in acute myeloid leukemia M1 and M5
54. Identification of complex genomic breakpoint junctions in the t(9;11) MLL-AF9 fusion gene in acute leukemia
55. Monitoring of minimal residual leukemia in patients with MLL-AF9 positive acute myeloid leukemia by RT-PCR
56. MLLT3 gene on 9p22 involved in t(9;11) leukemia encodes a serine/proline rich protein homologous to MLLT1 on 19p13
57. A novel type of MLL/AF10 fusion transcript in a child with acute megakaryocytic leukemia (AML-M7)
58. A novel MLL-AF10 fusion mRNA variant in a patient with acute myeloid leukemia detected by a new asymmetric reverse transcription PCR method
59. The t(10;11) translocation in acute myeloid leukemia (M5) consistently fuses the leucine zipper motif of AF10 onto the HRX gene
60. A novel class of zinc finger/leucine zipper genes identified from the molecular cloning of the t(10;11) translocation in acute leukemia
61. ENL, the gene fused with HRX in t(11;19) leukemias, encodes a nuclear protein with transcriptional activation potential in lymphoid and myeloid cells
62. Molecular analysis of t(11;19) breakpoints in childhood acute leukemias
63. Cloning of several species of MLL/MEN chimeric cDNAs in myeloid leukemia with t(11;19)(q23;p13.1) translocation
64. Cloning of ELL, a gene that fuses to MLL in a t(11;19)(q23;p13.1) in acute myeloid leukemia
65. Ten novel 11q23 chromosomal partner sites